With us today is Ivan Kairatov, a biopharma expert with deep experience in research and development, to discuss the evolving story of Sarepta’s gene therapy, Elevidys. We’ll explore how new long-term data is reshaping the clinical conversation around the therapy’s effectiveness, the commercial
A groundbreaking medical research initiative is taking root in Southern Nevada, positioning Las Vegas at the forefront of the global fight against Alzheimer’s disease through a pivotal partnership between the local practice Clinical Neurology Specialists (CNS) and the Global Alzheimer’s Platform
In the face of a life-altering diagnosis, the search for hope can lead patients and their families down countless digital rabbit holes, where unscrupulous vendors lie in wait with promises of miraculous cures sold through slick websites and persuasive social media campaigns. The U.S. Food and Drug
In the high-stakes world of biopharma, few stories are as compelling as the race to develop a successor to a multi-billion-dollar drug. We're joined today by Ivan Kairatov, a biopharma expert with deep experience in research, development, and the intricate dance between clinical data and commercial
A groundbreaking collaborative study has revealed a critical vulnerability within the human immune system, uncovering a sophisticated mechanism of viral sabotage that fundamentally alters our understanding of how pathogens outsmart our natural defenses. Research has identified a single tissue
For millions of people who rely on proton pump inhibitors (PPIs) to manage chronic acid reflux and other gastrointestinal conditions, a persistent concern has long cast a shadow over their treatment: the potential risk of developing stomach cancer. This decades-old question has fueled anxiety among
